Estimating Potential for Drug Budget Reallocation Following Expiration of Exclusivity of Pharmaceutical Products

Background: The prioritization of public funds in an equitable and ethically sound manner along with efficient budget allocation are key challenges for governments and budget holders. Following the introduction of generics/biosimilars, the potential total budget made available for reallocation resul...

Descripción completa

Detalles Bibliográficos
Autores principales: Toghanian, Samira, Moshtaghi-Svensson, John, Papageorgiou, Maria, Kittelsen, Kristin, Dolk, Christiaan, Hultstrand, Markus, Salomonsson, Stina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2022
Materias:
Methodology and Healthcare Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813194/
https://www.ncbi.nlm.nih.gov/pubmed/35178466
http://dx.doi.org/10.36469/jheor.2022.29624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813194/
https://www.ncbi.nlm.nih.gov/pubmed/35178466
http://dx.doi.org/10.36469/jheor.2022.29624

Ejemplares similares